vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Creative Media & Community Trust Corp (CMCT). Click either name above to swap in a different company.
Creative Media & Community Trust Corp is the larger business by last-quarter revenue ($28.5M vs $19.2M, roughly 1.5× Apyx Medical Corp). Apyx Medical Corp runs the higher net margin — -6.8% vs -125.8%, a 119.0% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 3.6%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -8.5%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.
APYX vs CMCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $28.5M |
| Net Profit | $-1.3M | $-11.4M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | -125.6% |
| Net Margin | -6.8% | -125.8% |
| Revenue YoY | 34.7% | 3.6% |
| Net Profit YoY | 71.9% | -11.4% |
| EPS (diluted) | — | $-3.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $28.5M | ||
| Q3 25 | $12.9M | $26.2M | ||
| Q2 25 | $11.4M | $29.7M | ||
| Q1 25 | $9.4M | $32.3M | ||
| Q4 24 | $14.2M | $27.5M | ||
| Q3 24 | $11.5M | $28.6M | ||
| Q2 24 | $12.1M | $34.4M | ||
| Q1 24 | $10.2M | $34.0M |
| Q4 25 | $-1.3M | $-11.4M | ||
| Q3 25 | $-2.0M | $-12.5M | ||
| Q2 25 | $-3.8M | $-9.0M | ||
| Q1 25 | $-4.2M | $-6.1M | ||
| Q4 24 | $-4.6M | $-10.3M | ||
| Q3 24 | $-4.7M | $-10.4M | ||
| Q2 24 | $-6.6M | $-796.0K | ||
| Q1 24 | $-7.6M | $-3.7M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | -125.6% | ||
| Q3 25 | -6.5% | -47.7% | ||
| Q2 25 | -22.6% | -30.3% | ||
| Q1 25 | -32.4% | -19.0% | ||
| Q4 24 | -21.4% | -128.8% | ||
| Q3 24 | -31.6% | -36.9% | ||
| Q2 24 | -45.7% | -1.6% | ||
| Q1 24 | -64.6% | -10.7% |
| Q4 25 | -6.8% | -125.8% | ||
| Q3 25 | -15.4% | -47.5% | ||
| Q2 25 | -33.2% | -30.3% | ||
| Q1 25 | -44.0% | -18.9% | ||
| Q4 24 | -32.5% | -129.8% | ||
| Q3 24 | -40.9% | -36.3% | ||
| Q2 24 | -54.0% | -2.3% | ||
| Q1 24 | -74.0% | -11.0% |
| Q4 25 | — | $-3.89 | ||
| Q3 25 | — | $-23.52 | ||
| Q2 25 | — | $-18.94 | ||
| Q1 25 | — | $-20.73 | ||
| Q4 24 | — | $97.71 | ||
| Q3 24 | — | $-305.04 | ||
| Q2 24 | $-0.19 | $-98.64 | ||
| Q1 24 | $-0.22 | $-125.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $15.4M |
| Total DebtLower is stronger | $37.5M | $509.8M |
| Stockholders' EquityBook value | $14.5M | $265.4M |
| Total Assets | $66.8M | $859.2M |
| Debt / EquityLower = less leverage | 2.58× | 1.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $15.4M | ||
| Q3 25 | $25.1M | $17.3M | ||
| Q2 25 | $29.3M | $27.8M | ||
| Q1 25 | $31.0M | $19.8M | ||
| Q4 24 | $31.7M | $20.3M | ||
| Q3 24 | $28.0M | $18.5M | ||
| Q2 24 | $32.7M | $29.3M | ||
| Q1 24 | $37.3M | $21.3M |
| Q4 25 | $37.5M | $509.8M | ||
| Q3 25 | $37.5M | $527.8M | ||
| Q2 25 | $37.5M | $535.6M | ||
| Q1 25 | $37.5M | $512.7M | ||
| Q4 24 | $37.5M | $505.7M | ||
| Q3 24 | $37.5M | $478.3M | ||
| Q2 24 | — | $485.1M | ||
| Q1 24 | — | $472.8M |
| Q4 25 | $14.5M | $265.4M | ||
| Q3 25 | $5.8M | $281.9M | ||
| Q2 25 | $7.3M | $287.1M | ||
| Q1 25 | $10.5M | $293.0M | ||
| Q4 24 | $14.2M | $304.5M | ||
| Q3 24 | $11.0M | $321.0M | ||
| Q2 24 | $14.7M | $351.1M | ||
| Q1 24 | $20.3M | $369.9M |
| Q4 25 | $66.8M | $859.2M | ||
| Q3 25 | $57.4M | $871.8M | ||
| Q2 25 | $58.2M | $885.0M | ||
| Q1 25 | $60.2M | $882.3M | ||
| Q4 24 | $64.8M | $889.6M | ||
| Q3 24 | $60.7M | $868.0M | ||
| Q2 24 | $65.4M | $891.2M | ||
| Q1 24 | $70.7M | $887.5M |
| Q4 25 | 2.58× | 1.92× | ||
| Q3 25 | 6.41× | 1.87× | ||
| Q2 25 | 5.17× | 1.87× | ||
| Q1 25 | 3.57× | 1.75× | ||
| Q4 24 | 2.64× | 1.66× | ||
| Q3 24 | 3.40× | 1.49× | ||
| Q2 24 | — | 1.38× | ||
| Q1 24 | — | 1.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $5.8M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $5.8M | ||
| Q3 25 | $-3.5M | $3.7M | ||
| Q2 25 | $-1.2M | $-2.5M | ||
| Q1 25 | $-702.0K | $1.2M | ||
| Q4 24 | $-2.9M | $17.0M | ||
| Q3 24 | $-4.4M | $10.3M | ||
| Q2 24 | $-4.3M | $3.9M | ||
| Q1 24 | $-6.3M | $1.6M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-757.0K | — | ||
| Q4 24 | $-3.2M | — | ||
| Q3 24 | $-4.6M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-6.4M | — |
| Q4 25 | -14.6% | — | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -8.0% | — | ||
| Q4 24 | -22.4% | — | ||
| Q3 24 | -40.0% | — | ||
| Q2 24 | -38.0% | — | ||
| Q1 24 | -62.2% | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 4.0% | — | ||
| Q2 25 | 2.3% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 1.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 0.3% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
